Atherosclerosis

Atherosclerosis is the progressive hardening and narrowing of the arteries caused by plaque buildup inside their walls. This plaque—made up of fats, cholesterol, calcium, and cellular debris—accumulates slowly, restricting blood flow and depriving organs of oxygen. The process can remain silent for years, but once a significant obstruction or rupture occurs, the result is often catastrophic: a heart attack, stroke, or sudden death.

Overview

What is atherosclerosis?

Atherosclerosis begins when the inner lining of the artery (endothelium) is damaged, often due to high blood pressure, smoking, diabetes, or chronic inflammation. This injury allows lipids and inflammatory cells to penetrate the vessel wall, forming plaque (atheroma). Over time, the wall thickens, hardens, and loses its elasticity. The narrowed artery reduces blood flow like a highway shrinking to one lane, while the constant force of circulation can rupture unstable plaque. When that happens, the body responds by forming a clot that can instantly block blood flow to the heart, brain, or limbs. A coronary artery clot triggers a heart attack; in the brain, it causes an ischemic stroke.

---

Prevalence

How common is atherosclerosis?

Atherosclerosis is one of the most widespread and deadly diseases on the planet. Cardiovascular complications from plaque buildup—heart attacks, strokes, and peripheral artery disease (PAD)—remain the leading global cause of death, responsible for more than 17 million deaths annually. In the United States, studies from the National Institutes of Health (NIH) estimate that nearly half of adults aged 45 to 84 already have measurable atherosclerosis and don’t know it, underscoring its silent and devastating reach.

---

Symptoms

What are the symptoms of atherosclerosis?

Atherosclerosis progresses silently for decades before presenting with warning signs. Most people have no idea they have arterial disease until the first symptom is catastrophic. By the time symptoms emerge, the artery is usually more than 70% blocked, and oxygen delivery to critical organs has already fallen below functional levels. The symptoms depend on which arteries are compromised, but the underlying process is identical across cases: restricted blood flow, tissue hypoxia, and the constant threat of thrombosis.

Heart

When plaque targets the arteries supplying the heart, it causes coronary artery disease (CAD)—the world’s leading cause of death. The narrowed arteries cannot deliver enough oxygen-rich blood during activity or stress, and even minimal exertion can trigger ischemic pain.

Symptoms include:

• Chest pain or pressure (angina) radiating to the jaw, neck, shoulders, arms, or back.

  
  

• Shortness of breath (dyspnea) during light activity or even at rest.

  
  

• Palpitations, dizziness, or fainting caused by oxygen-starved heart muscle or arrhythmias.

  
  

• Fatigue, nausea, or vomiting—symptoms often mistaken for heartburn or anxiety, especially in women.

A complete coronary blockage results in myocardial infarction (heart attack), permanently damaging heart tissue. In some cases, the first sign of disease is instant cardiac arrest.

Digestive System

When atherosclerosis obstructs blood flow through the mesenteric arteries, it leads to mesenteric ischemia—a dangerous reduction in oxygen to the intestines, particularly after meals when demand spikes.

Symptoms include:

• Severe abdominal pain or cramping after eating that intensifies with each episode.

  
  

• Nausea, bloating, or vomiting minutes after meals.

  
  

• Chronic diarrhea or persistent digestive distress.

  
  

• Severe, unintentional weight loss due to “food fear”—the avoidance of eating to prevent pain.

Without intervention, repeated ischemia can destroy intestinal tissue, leading to necrosis, sepsis, and death.

Legs and Feet

Atherosclerosis in the arteries of the limbs causes peripheral artery disease (PAD)—a visible warning of systemic vascular disease. The same process threatening the legs is almost always occurring in the coronary and carotid arteries as well.

Symptoms include:

• Cramping or burning pain while walking (intermittent claudication) that disappears with rest.

  
  

• Burning or aching in the feet or toes at rest, especially when lying flat.

  
  

• Cold, pale, or bluish skin, thinning hair, or brittle nails.

  
  

• Sores, ulcers, or infections on the feet or toes that fail to heal are a sign of tissue death and impending amputation.

PAD is not a peripheral issue; it is often the first visible sign of widespread atherosclerosis throughout the body.

Kidneys

Atherosclerosis of the renal arteries—known as renal artery stenosis—reduces blood flow to the kidneys, triggering high blood pressure and gradual kidney failure.

Symptoms include:

• Severe, resistant hypertension that doesn’t respond to multiple medications.

  
  

• Fluid retention and swelling (edema) in the legs, feet, or face.

  
  

• Fatigue, drowsiness, or decreased urination as toxins accumulate in the blood.

  
  

• Nausea, appetite loss, and unexplained weight loss.

  
  

• Dry, itchy, or numb skin caused by toxin buildup (uremia).

Untreated renal ischemia leads to irreversible kidney scarring and, ultimately, renal failure requiring dialysis.

Brain

When plaque narrows the carotid arteries, which deliver oxygen to the brain, it can cause a transient ischemic attack (TIA) or a full ischemic stroke—both medical emergencies that can result in permanent disability or death.

Symptoms appear suddenly and may include:

• Weakness, numbness, or paralysis on one side of the body or face.

  
  

• Slurred speech or difficulty forming words.

  
  

• Partial vision loss in one eye, described as a dark curtain descending over the field of vision.

  
  

• Dizziness, confusion, or a severe, sudden headache.

Roughly 15% of major strokes are preceded by a TIA within days. Early recognition and emergency treatment during this window can mean the difference between full recovery and irreversible brain damage.

---

Causes

What are the most common causes of atherosclerosis?

Atherosclerosis begins when the endothelium, the delicate inner lining of medium and large arteries, ceases to function as a smooth, selectively permeable barrier and shifts into a chronically inflamed state. The most powerful drivers are well established, but recent data highlight additional, less recognized contributors.

• High LDL and Triglyceride-Rich Lipoproteins: Low-density lipoprotein (LDL) and triglyceride-rich remnant particles cross a dysfunctional endothelium and become trapped in the arterial wall. Once retained, these particles undergo chemical modification (oxidation or glycation), thereby triggering an inflammatory response and recruiting immune cells. Genetic and pharmacologic studies consistently show that the lifetime burden of LDL and other apolipoprotein B-containing lipoproteins is a causal driver of atherosclerotic cardiovascular disease (ASCVD).

  
  

• Hypertension and Disturbed Blood Flow: Chronically elevated blood pressure subjects arteries to abnormal shear stress and cyclic stretch. This mechanical stress is most damaging at branch points and curvatures, where blood flow is already disturbed. Endothelial cells in these regions switch on pro-inflammatory and pro-thrombotic gene programs, making them “hot spots” for plaque initiation and growth.

  
  

• Tobacco and Nicotine Exposure: Cigarette smoke, vaping aerosols, and other combustion products deliver reactive chemicals that impair nitric oxide signaling, increase oxidative stress, and promote endothelial cell death. These exposures also increase platelet reactivity and promote a more thrombogenic blood profile, thereby accelerating both plaque development and the risk of acute clot formation at sites of plaque disruption.

  
  

• Diabetes, Insulin Resistance, and Metabolic Syndrome: Chronic hyperglycemia and insulin resistance heighten oxidative stress, increase advanced glycation end products, and amplify low-grade inflammation throughout the vasculature. People with diabetes develop plaques that are richer in lipid, more inflamed, and more prone to rupture, and their risk of ASCVD events is roughly doubled compared with those without diabetes, even after accounting for traditional risk factors.

  
  

• Obesity, Physical Inactivity, and Diet: Excess visceral adiposity functions as an inflammatory endocrine organ, releasing cytokines that worsen insulin resistance and endothelial dysfunction. Diets high in saturated and trans fats, refined carbohydrates, and added sugars, and low in fiber and unsaturated fats, raise LDL cholesterol, triglycerides, and blood pressure while impairing vascular health. Regular physical activity has the opposite effect. It improves endothelial function, lowers inflammatory markers, and is independently associated with lower plaque burden and fewer ASCVD events.

  
  

• Chronic Kidney Disease (CKD): Reduced kidney function promotes hypertension, dyslipidemia, mineral and bone disorders, and uremic toxins that directly injure the endothelium. Patients with moderate to severe chronic kidney disease develop accelerated and often more calcified atherosclerosis, with cardiovascular disease as a leading cause of death.

  
  

• Systemic Inflammation and Autoimmune Disease: Chronic inflammatory conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), psoriasis, inflammatory bowel disease, and HIV infection carry a substantially elevated risk of premature ASCVD. Persistent immune activation alters lipid handling, increases cytokine release, and destabilizes existing plaques. In HIV specifically, subclinical atherosclerosis, myocardial infarction, and heart failure occur more frequently even after adjustment for traditional risk factors, which underscores the vascular impact of ongoing immune dysregulation.

  
  

• Lipoprotein(a) and Genetic Susceptibility: Elevated lipoprotein(a) [Lp(a)] is now recognized as one of the most common inherited risk factors for ASCVD. Lp(a) carries oxidized phospholipids, promotes inflammation, and interferes with fibrinolysis, which means it can both accelerate plaque growth and increase the likelihood of thrombus formation when plaques rupture. High Lp(a) levels confer a significantly higher risk of major cardiovascular events independent of LDL, and this effect appears to be magnified in autoimmune populations.

  
  

• Clonal Hematopoiesis: Somatic mutations in hematopoietic stem cells that lead to clonal hematopoiesis of indeterminate potential (CHIP) create a population of myeloid cells with exaggerated inflammatory signaling. CHIP is increasingly recognized as an independent risk factor for atherosclerotic cardiovascular disease, thrombosis, and heart failure, largely because these mutant immune cells promote plaque inflammation and destabilization.

  
  

• Sleep, Psychosocial Stress, and Neurocardiovascular Factors: Suboptimal sleep duration, irregular sleep timing, and sleep disorders such as obstructive sleep apnea are associated with increased rates of hypertension, diabetes, obesity, and ASCVD events. Sleep has been formally incorporated into major cardiovascular health metrics. Chronic psychosocial stress, depression, and anxiety are also associated with adverse cardiovascular outcomes through autonomic imbalance, elevated catecholamines, endothelial dysfunction, and unhealthy coping behaviors.

  
  

• Environmental and Early-Life Factors: Long-term exposure to fine particulate air pollution, heavy metals, and certain occupational toxins is associated with more extensive atherosclerosis and higher rates of cardiovascular events. Adverse pregnancy outcomes, early-life undernutrition, and childhood exposure to smoking or poor diet all appear to program vascular risk decades before clinical disease emerges.

The body initially responds to endothelial injury as if it were repairing a wound. Lipoproteins, platelets, and immune cells are recruited to the site of damage to contain and stabilize the injury. Over time, however, this repair process becomes maladaptive. Lipids accumulate, inflammatory cells persist, and a fibrofatty plaque grows inside the arterial wall instead of true vessel healing. The plaque’s fatty core and fibrous cap thicken and remodel the artery. Eventually, plaque disruption exposes the thrombogenic core to circulating blood, thereby triggering a clot that can partially or completely block blood flow within seconds.

---

Stages

What are the stages of atherosclerosis?

The evolution of atherosclerosis is gradual and often silent. Pathology and imaging studies describe a sequence from microscopic endothelial dysfunction to complex, rupture-prone plaques.

Endothelial Damage and Immune Activation

Atherosclerosis begins when endothelial cells are exposed to sustained mechanical stress, toxins, or inflammatory signals. Hypertension, smoking, diabetes, elevated LDL, and disturbed flow at arterial branch points are the most consistent triggers. Once damaged, endothelial cells express adhesion molecules and chemokines that invite circulating monocytes and T cells into the arterial wall. These immune cells release cytokines and generate reactive oxygen species, which amplify local inflammation and impair normal nitric oxide-mediated vasodilation. What began as a microscopic injury becomes a chronic, self-sustaining inflammatory focus.

Fatty Streaks and Early Intimal Thickening

The earliest visible lesions are fatty streaks and adaptive intimal thickenings. LDL and other apolipoprotein B-containing particles retained in the intima are taken up by recruited macrophages. Once engorged with lipid, these macrophages transform into foam cells. Foam cells eventually die and spill their lipid contents, which further fuels inflammation. Autopsy studies have shown that these fatty streaks and foam cell collections are present in adolescents and even in late childhood, particularly in the aorta and coronary ostia, long before any symptoms appear.

At this stage, the artery may still appear normal on standard imaging because the vessel wall remodels outward to preserve the lumen, a process known as positive or expansive remodeling. The disease remains clinically silent even as the groundwork for future plaque is established.

Plaque Growth and Vascular Remodeling

As exposure to risk factors continues, foam cell debris, extracellular cholesterol crystals, smooth muscle cells, and collagen accumulate to form an atheromatous plaque with a lipid-rich necrotic core and a fibrous cap. Smooth muscle cells migrate from the media into the intima and synthesize collagen and extracellular matrix to reinforce this cap. The plaque thickens, and the artery wall becomes stiffer and less compliant.

During this phase, the artery may continue to remodel outward, which can mask the presence of substantial plaque on lumen-based imaging until the disease is advanced. When the plaque encroaches on the lumen, blood flow is restricted, particularly during exertion, when oxygen demand increases. In coronary arteries, this often corresponds to stable angina, predictable chest discomfort with physical or emotional stress that improves with rest or nitroglycerin.

Transition From Stable to Vulnerable Plaque

Not all plaques behave the same way. Some evolve into relatively stable, heavily fibrotic or calcified lesions that narrow the lumen but are less likely to rupture. Others become vulnerable plaques characterized by a large lipid core, a thin fibrous cap, abundant inflammatory cells, particularly macrophages and certain T-cell subsets, and dense neovascularization from fragile microvessels that can bleed into the plaque. Intraplaque hemorrhage, ongoing inflammation, and enzymatic degradation of collagen weaken the cap and increase mechanical stress at its shoulders, where rupture frequently occurs.

These vulnerable plaques do not always cause severe pre-event narrowing. Many culprit lesions responsible for myocardial infarction are only moderately stenotic on prior angiography, which highlights that plaque composition and inflammatory activity are often more important than the degree of visible narrowing.

Plaque Rupture, Erosion, and Thrombosis

The final, life-threatening stage occurs when the fibrous cap ruptures or when the endothelial layer erodes over an inflamed, lipid-rich plaque. Rupture tears the cap and exposes the thrombogenic necrotic core directly to circulating blood. Erosion strips away the endothelial layer while the cap remains structurally intact. Both scenarios activate platelets and the coagulation cascade, causing a thrombus to form on the plaque surface. In some cases, the clot partially occludes the lumen, causing unstable angina. In others, it abruptly seals the artery, producing an acute myocardial infarction or ischemic stroke.

Autopsy and imaging studies show that, among individuals who die suddenly with coronary thrombosis, plaque rupture accounts for roughly two-thirds of cases, plaque erosion for about one-third, and calcified nodules for a small minority. Coronary artery disease as a whole underlies approximately half to three-quarters of sudden cardiac deaths, and an acute thrombus on a disrupted plaque is identified in most sudden coronary deaths.

Thrombi do not always cause immediate death or infarction. Some organize and heal, leaving behind thicker, more complex plaques with layered fibrous tissue and further narrowing of the lumen. Serial pathology series suggest that many advanced plaques represent the cumulative result of multiple episodes of silent rupture or erosion and healing over time, which gradually transform an initially small lesion into a critical obstruction.

---

Risk Factors

What are the risk factors for atherosclerosis?

Atherosclerosis develops fastest when several cardiovascular risk factors converge on the arterial wall at the same time. Some are not modifiable, such as age and inherited traits. Others can be altered through lifestyle, medication, or treatment of the underlying disease. All of them work in the same direction: they accelerate endothelial injury, lipid retention, and chronic vascular inflammation.

Major Nonmodifiable Risk Factors

• Age and Sex: Being male over age 45 or female over age 55 increases risk because decades of exposure to blood pressure, lipids, and metabolic stress gradually damage the arterial wall.

  
  

• Family History of Premature Cardiovascular Disease: Having a first-degree relative with a heart attack, stroke, or sudden cardiac death before age 55 in a man or 65 in a woman suggests inherited vulnerability in lipids, clotting, or vascular biology.

  
  

• Genetic Lipid Disorders and Elevated Lipoprotein(a): Familial hypercholesterolemia, familial combined hyperlipidemia, and elevated lipoprotein(a) [Lp(a)] create high lifetime exposure to atherogenic particles even in people who otherwise appear healthy, which markedly accelerates plaque formation.

  
  

• Certain Ancestries With Higher Baseline Risk: Individuals of South Asian, some Middle Eastern, or African ancestry often show higher rates of premature atherosclerotic disease at similar levels of traditional risk factors, reflecting a mixture of genetic and environmental influences.

  
  

Metabolic and Endocrine Risk Factors

• Diabetes Mellitus: Type 1 and type 2 diabetes substantially increase the risk of coronary artery disease, stroke, and peripheral arterial disease through chronic hyperglycemia, glycation of vascular proteins, oxidative stress, and microvascular damage. Cardiovascular disease remains a leading cause of death in diabetes.

  
  

• Insulin Resistance and Metabolic Syndrome: Central abdominal obesity, elevated fasting glucose, high triglycerides, low HDL cholesterol, and hypertension collectively constitute metabolic syndrome. This pattern signals a prolonged pro-inflammatory and pro-thrombotic state that accelerates atherosclerosis even before overt diabetes develops.

  
  

• High LDL Cholesterol and Triglyceride-Rich Lipoproteins: Elevated LDL cholesterol, remnant particles, and apolipoprotein B concentrations expose the endothelium to a constant flow of atherogenic lipoproteins. The higher and more prolonged the exposure, the greater the cumulative plaque burden.

  
  

• Low HDL Cholesterol: Low HDL cholesterol often accompanies insulin resistance and high triglycerides. While raising HDL levels directly has not improved outcomes, a low HDL value often reflects an underlying metabolic pattern that promotes atherosclerosis.

  
  

• Chronic Kidney Disease: Reduced kidney function is associated with dyslipidemia, hypertension, and uremic toxins that harm the endothelium. Cardiovascular mortality rises sharply in those with chronic kidney disease as kidney function declines, even at moderate levels of impairment.

  
  

Blood Pressure and Vascular Risk Factors

• Hypertension: Persistently elevated blood pressure increases shear stress on artery walls, especially at branch points where flow is turbulent. This mechanical strain accelerates endothelial dysfunction, plaque formation, and left ventricular hypertrophy.

  
  

• Pulse Pressure and Arterial Stiffness: Wide pulse pressure and stiff large arteries reflect advanced vascular aging. These changes increase systolic load on the heart and are associated with greater plaque burden and higher event risk, particularly in older adults.

  
  

Lifestyle and Behavioral Risk Factors

• Smoking and Tobacco Exposure: Active cigarette smoking, vaping, and other nicotine products damage the endothelium, increase oxidative stress, and promote a pro-thrombotic blood profile. Even low daily exposure and secondhand smoke increase risk.

  
  

• Sedentary Lifestyle: Physical inactivity contributes to weight gain, insulin resistance, and higher blood pressure. Regularly engaging in moderate- or vigorous-intensity activity improves endothelial function, reduces inflammation, and lowers the incidence of cardiovascular events.

  
  

• Dietary Pattern: Diets high in saturated fat, trans fat, refined carbohydrates, added sugars, and sodium and low in fruits, vegetables, whole grains, and unsaturated fats raise LDL cholesterol and blood pressure and worsen glycemic control. Over time, this pattern speeds plaque development.

  
  

• Excess Alcohol Use: Heavy or binge drinking elevates blood pressure, promotes cardiomyopathy, and can worsen triglycerides and arrhythmia risk, all of which amplify vascular risk.

  
  

Inflammatory, Autoimmune, and Hematologic Risk Factors

• Chronic Inflammatory and Autoimmune Diseases: Conditions such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and chronic infections are characterized by heightened immune activation. This persistent inflammation destabilizes plaques and increases the likelihood of premature cardiovascular events.

  
  

• Clonal Hematopoiesis Of Indeterminate Potential (CHIP): Age-related mutations in hematopoietic stem cells create clones of inflammatory blood cells that infiltrate plaques, promote inflammation, and increase risk of coronary events and stroke, even when traditional risk factors are controlled.

  
  

• Hypercoagulable States: Inherited or acquired clotting disorders, malignancy, and certain medications can increase the tendency to form thrombi on disrupted plaques, which raises the risk of heart attack and stroke.

  
  

Sex-Specific and Hormonal Risk Factors

• Premature Menopause and Surgical Menopause: Loss of ovarian hormones before the typical age range, whether spontaneous or surgical, removes vascular protective effects earlier in life and increases long-term cardiovascular risk.

  
  

• Pregnancy-Related Complications: A history of preeclampsia, gestational hypertension, gestational diabetes, placental abruption, or preterm birth signals an underlying vascular or metabolic vulnerability. These women face higher rates of hypertension, diabetes, and ASCVD later in life.

  
  

• Polycystic Ovary Syndrome (PCOS): Polycystic ovary syndrome (PCOS) often includes insulin resistance, dyslipidemia, and central obesity, which collectively heighten atherosclerotic risk over time.

  
  

Sleep, Psychosocial, and Environmental Risk Factors

• Sleep Apnea and Sleep Disruption: Obstructive sleep apnea, short sleep duration, poor sleep quality, and irregular sleep schedules are associated with higher rates of hypertension, arrhythmias, insulin resistance, and ASCVD events.

  
  

• Chronic Psychosocial Stress, Depression, and Anxiety: Sustained stress and mood disorders are linked with autonomic imbalance, elevated catecholamines, higher inflammatory markers, unhealthy coping behaviors, and reduced adherence to treatment, all of which compound cardiovascular risk.

  
  

• Environmental Exposures: Long-term exposure to air pollution, heavy metals, and certain occupational chemicals accelerates vascular aging and increases event rates, particularly among individuals with traditional risk factors.

  
  

• Social and Structural Determinants of Health: Limited access to nutritious food, safe environments for physical activity, stable housing, and consistent access to healthcare contribute to higher prevalence of risk factors and earlier onset of atherosclerotic disease.

The risk of atherosclerosis does not rise in a simple linear fashion. When multiple factors coexist, they interact and amplify each other. For example, a person with diabetes, hypertension, and high LDL cholesterol who also smokes has a far higher risk than any single factor would suggest. This cumulative burden determines the timing of plaque formation, the rate of plaque progression, and the likelihood of plaque rupture and the development of heart attack, stroke, or peripheral arterial disease.

---

Complications

What are the complications of atherosclerosis?

As plaque accumulates and arterial walls stiffen, blood flow becomes restricted, and blood clots form on disrupted plaques. Oxygen delivery falls below what tissues require. The result is ischemia, infarction, and progressive organ dysfunction throughout the body. The exact complication depends on which vascular bed is affected, but the underlying mechanism is the same: an unstable artery fails the tissue it was meant to supply.

Cardiac Complications

• Coronary Artery Disease and Angina: Narrowing of the coronary arteries limits blood flow to the heart muscle. This produces exertional chest discomfort or pressure that improves with rest or nitroglycerin, often described as stable angina. When plaques inflame and partially thrombose, chest pain can become more frequent, occur at rest, or change in pattern, which signals unstable angina and a much higher short-term risk of heart attack.

  
  

• Heart Attack (Myocardial Infarction): Sudden plaque rupture or erosion in a coronary artery can trigger a clot that abruptly blocks blood flow. Prolonged occlusion during a myocardial infarction causes irreversible death of the heart muscle. The extent and location of infarction determine the risk of shock, heart failure, arrhythmias, and long-term disability.

  
  

• Sudden Cardiac Death: Ventricular fibrillation or pulseless ventricular tachycardia can occur minutes after an acute coronary event, sometimes before any warning symptoms. In many adults, sudden cardiac death represents the first clinical presentation of coronary atherosclerosis.

  
  

• Arrhythmias and Conduction Disorders: Scarred or oxygen-starved myocardium disrupts the heart’s electrical pathways. This can lead to atrial fibrillation, ventricular tachycardia or fibrillation, frequent ventricular ectopy, and conduction blocks. These rhythm disturbances can cause palpitations, syncope, heart failure, stroke from atrial thrombus, or sudden death.

  
  

• Heart Failure and Ischemic Cardiomyopathy: Repeated ischemic episodes and prior infarcts weaken the heart’s pumping ability. The left ventricle may dilate and remodel into an inefficient shape. Patients develop shortness of breath, fluid overload, reduced exercise tolerance, and frequent hospitalizations. In advanced cases, mechanical support or transplantation may be required.

  
  

• Mechanical Complications of Infarction: Large or strategically placed infarcts can rupture the ventricular wall, create ventricular septal defects, or damage papillary muscles that support the mitral valve. These acute structural failures cause severe hypotension, pulmonary edema, and high early mortality without urgent intervention.

  
  

Cerebrovascular and Neurologic Complications

• Carotid Artery Disease: Narrowing or ulceration of the carotid arteries in the neck increases the risk of emboli breaking loose and traveling to the brain. Many patients remain asymptomatic until a transient ischemic attack or stroke occurs.

  
  

• Stroke and Transient Ischemic Attack (TIA): Atherosclerotic plaques in the carotid arteries, vertebral arteries, or intracranial vessels can rupture or thrombose, blocking cerebral blood flow. Transient ischemic attacks (TIAs) cause temporary neurological deficits that resolve within twenty-four hours. Ischemic strokes cause lasting deficits such as weakness, speech problems, visual loss, or cognitive changes. Large strokes can be fatal.

  
  

• Vascular Cognitive Impairment and Dementia: Repeated small vessel infarcts, chronic hypoperfusion, or a combination of Alzheimer’s pathology and vascular disease can gradually erode cognitive function. Patients may develop slowed thinking, executive dysfunction, gait disturbance, and eventual loss of independence.

  
  

• Retinal Artery Occlusion and Ocular Ischemia: Atherosclerotic emboli can lodge in retinal arteries, producing sudden, painless monocular vision loss. Chronic carotid disease can also cause ocular ischemic syndrome with visual disturbances and eye pain.

  
  

Peripheral Vascular Complications

• Peripheral Artery Disease (PAD): Atherosclerosis of the arteries of the legs, known as peripheral artery disease (PAD), causes intermittent claudication, cramping, or aching pain during walking that improves with rest. As the disease advances, patients may develop rest pain, nonhealing ulcers, infections, and tissue loss.

  
  

• Critical Limb Threatening Ischemia and Amputation: Severe PAD with rest pain, ulcers, or gangrene represents critical limb-threatening ischemia. Without timely revascularization, patients risk major amputation, sepsis, and high subsequent mortality.

  
  

• Atheroembolism and “Blue Toe” Syndrome: Cholesterol crystals and plaque debris can shower downstream from ulcerated aortic or peripheral plaques. This causes painful, discolored digits, livedo reticularis, renal dysfunction, or skin lesions despite palpable major pulses.

  
  

• Subclavian and Upper Extremity Disease: Atherosclerosis of the subclavian or arm arteries can cause arm claudication, arm-to-arm blood pressure discrepancy, or coronary subclavian steal in patients with internal mammary grafts, in which arm exercise diverts blood away from the heart.

Aortic and Large Artery Complications

• Aneurysm Formation: Chronic inflammation and structural weakening of the aortic wall can lead to aneurysmal dilation, particularly in the abdominal aorta. Many aneurysms are silent until they expand rapidly or leak.

  
  

• Aneurysm Rupture: Rupture of an abdominal or thoracic aortic aneurysm causes massive internal hemorrhage, profound hypotension, and very high mortality even with emergency surgery.

  
  

• Dissection In A Diseased Aorta: Although classic dissection often relates to hypertension and degenerative medial disease, underlying atherosclerosis contributes to wall fragility. Aortic dissection can compromise branches that supply the brain, spinal cord, kidneys, or intestines, leading to sudden, multi-organ ischemia.

  
  

Renal and Visceral Complications

• Renal Artery Stenosis and Ischemic Nephropathy: Atherosclerotic narrowing of the renal arteries reduces kidney perfusion. This can cause progressive loss of kidney function, resistant hypertension, and episodes of flash pulmonary edema due to abrupt fluid shifts.

  
  

• Chronic Kidney Disease (CKD): Repeated ischemic injury and vascular remodeling in the kidneys contribute to CKD. As renal function declines, cardiovascular risk rises further, creating a vicious cycle between kidney disease and atherosclerosis.

  
  

• Acute and Chronic Mesenteric Ischemia: Atherosclerosis of the mesenteric arteries can cause postprandial abdominal pain, weight loss, and food avoidance in chronic mesenteric ischemia. Sudden thrombosis or embolic occlusion produces acute mesenteric ischemia, a surgical emergency that can progress to bowel infarction, sepsis, and death.

  
  

Other Systemic and Organ-Specific Complications

• Erectile Dysfunction: Narrowing of the penile arteries, which are smaller than the coronary arteries, often appears early in systemic atherosclerosis. Erectile dysfunction can be an early warning sign of widespread vascular disease.

  
  

• Skin Ulcers and Poor Wound Healing: Reduced blood flow to the skin and subcutaneous tissues, particularly in the lower extremities, impairs wound repair. Minor trauma can progress to chronic ulcers and infection, especially in patients with diabetes and PAD.

  
  

• Overlap of Vascular Beds and Polyvascular Disease: Many patients develop significant plaque in multiple arterial territories simultaneously. For example, an individual with coronary disease may also have carotid stenosis and PAD. Polyvascular disease is associated with higher rates of recurrent heart attack, stroke, limb loss, and death than involvement of a single vascular bed.

Atherosclerosis often begins unfolding years before the first event. Once a clinically significant complication, such as a heart attack, stroke, or critical limb ischemia, occurs, the risk of subsequent events rises sharply. Each new plaque rupture, thrombus, or ischemic injury adds scar tissue, destabilizes remaining plaques, and narrows the margin of safety. What begins as a chronic, system-wide process can, without warning, convert into a sudden, life-ending event.

---

The IWBCA provides the information and materials on this site for educational and informational purposes only. The content is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider regarding any questions you may have about a medical condition, diagnosis, or course of treatment. Do not disregard, delay, or alter medical advice based on information obtained from this site. If you believe you are experiencing a medical emergency, call 911 or your local emergency services immediately.